反式肩关节置换术与半肩关节置换术及非手术治疗用于老年急性肱骨近端三部分或四部分骨折的比较:随机对照试验研究方案(PROFHER-2:肱骨近端骨折随机化评估试验2)
PROFHER-2为实用型多中心随机试验,计划从英国约40家NHS医院招募65岁以上急性影像学确诊的三部分或四部分肱骨近端骨折患者,比较反式肩关节置换术、半肩关节置换术与非手术治疗的临床与成本效果。主要结局为24个月时牛津肩关节评分,目标样本量380例,按2:2:1(半肩关节置换术:反式肩关节置换术:非手术)随机分配无关节脱位者,按1:1(半肩关节置换术:反式肩关节置换术)随机分配骨折脱位者。
要点
- PROFHER-2试验比较反式肩关节置换术、半肩关节置换术与非手术治疗老年肱骨近端三部分或四部分骨折。
- 主要结局为24个月时牛津肩关节评分,目标招募380例,来自英国约40家NHS医院。
- 无关节脱位者按2:2:1随机分配,骨折脱位者按1:1随机分配。
核心结论
- PROFHER-2试验旨在为65岁及以上肱骨近端三部分或四部分骨折患者的治疗提供可靠答案。
研究设计与样本
- 实用型多中心随机对照试验,从英国约40家NHS医院招募65岁以上急性影像学确诊的三部分或四部分肱骨近端骨折患者,伴或不伴盂肱关节脱位。
- 排除多发伤、开放性骨折、腋神经麻痹、病理性骨折(非骨质疏松性)及无法遵守试验流程者。
- 目标招募380例(反式肩关节置换术152例、半肩关节置换术152例、非手术76例),无关节脱位者按2:2:1(半肩关节置换术:反式肩关节置换术:非手术)随机,骨折脱位者按1:1(半肩关节置换术:反式肩关节置换术)随机。
关键数值与推荐
- 主要结局为24个月时牛津肩关节评分。
- 次要结局包括生活质量(EQ-5D-5L)、疼痛、肩关节活动度、X线骨折愈合与植入物位置、进一步手术及并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Proximal humerus fractures (PHF) are common and painful injuries, with the majority resulting from falls from a standing height. As with other fragility fractures, its age-specific incidence is increasing. Surgical treatment with hemiarthroplasty (HA) and reverse shoulder arthroplasty (RSA) have been increasingly used for displaced 3- and 4-part fractures despite a lack of good quality evidence as to whether one type of arthroplasty is superior to the other, and whether surgery is better than non-surgical management. The PROFHER-2 trial has been designed as a pragmatic, multicentre randomised trial to compare the clinical and cost-effectiveness of RSA vs HA vs Non-Surgical (NS) treatment in patients with 3- and 4-part PHF. METHODS: Adults over 65 years of age presenting with acute radiographically confirmed 3- or 4-part fractures, with or without associated glenohumeral joint dislocation, who consent for trial participation will be recruited from around 40 National Health Service (NHS) Hospitals in the UK. Patients with polytrauma, open fractures, presence of axillary nerve palsy, pathological (other than osteoporotic) fractures, and those who are unable to adhere to trial procedures will be excluded. We will aim to recruit 380 participants (152 RSA, 152 HA, 76 NS) using 2:2:1 (HA:RSA:NS) randomisation for 3- or 4-part fractures without joint dislocation, and 1:1 (HA:RSA) randomisation for 3- or 4-part fracture dislocations. The primary outcome is the Oxford Shoulder Score at 24 months. Secondary outcomes include quality of life (EQ-5D-5L), pain, range of shoulder motion, fracture healing and implant position on X-rays, further procedures, and complications. Independent Trial Steering Committee and Data Monitoring Committee will oversee the trial conduct, including the reporting of adverse events and harms. DISCUSSION: The PROFHER-2 trial is designed to provide a robust answer to guide the treatment of patients aged 65 years or over who sustain 3- and 4-part proximal humeral fractures. The pragmatic design and recruitment from around 40 UK NHS hospitals will ensure immediate applicability and generalisability of the trial findings. The full trial results will be made available in a relevant open-access peer-reviewed journal. TRIAL REGISTRATION: ISRCTN76296703. Prospectively registered on 5th April 2018.
引用
- Rangan A, Gwilym S, Keding A, et al. Reverse shoulder arthroplasty versus hemiarthroplasty versus non-surgical treatment for older adults with acute 3- or 4-part fractures of the proximal humerus: study protocol for a randomised controlled trial (PROFHER-2: PROximal Fracture of Humerus Evaluation by Randomisation - Trial Number 2). Trials. 2023. PMID: 37055816. doi:10.1186/s13063-023-07259-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。